Quantcast

Latest Melanoma Stories

2014-06-02 08:29:32

Phase 1 Study Evaluating Talimogene Laherparepvec Plus Ipilimumab Showed Tolerability at Doses Administered THOUSAND OAKS, Calif., June 2, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced new data from two key clinical trials that support the potential of talimogene laherparepvec, a novel, investigational oncolytic immunotherapy, as both a single agent and as part of a combination regimen in patients with metastatic melanoma. The findings were presented at the 50th...

2014-06-01 08:20:47

The study met the primary endpoint with objective response rates of 41.8% and 32.5% respectively in the 200 mg and 800 mg treatment arms(1,2) EAST HANOVER, N.J., June 1, 2014 /PRNewswire/ -- Novartis announced today the results of a pivotal Phase II trial demonstrating that patients with locally advanced (laBCC) or metastatic basal cell carcinoma (mBCC) taking the investigational oral compound LDE225 (sonidegib) had marked and sustained tumor shrinkage after a median follow-up of...

2014-05-31 08:21:17

Data Support Adoption of Stable Disease as Response Criterion, Raise Intriguing Hypotheses about Sequential Therapy and Utility of IL-2 as Salvage Option CHICAGO, May 31, 2014 /PRNewswire/ -- Prometheus Laboratories Inc. announced today that data from the PROCLAIM(SM) national patient registry retrospective cohort document an improvement in median overall survival (OS) in patients with metastatic melanoma who were treated with high-dose Proleukin(®) (aldesleukin) as compared to...

2014-05-30 23:01:38

An assortment of SupportStore rubber wristbands, lapel pins, and other items remind adults and children to respect the dangers of too much sun. Chicago, IL (PRWEB) May 30, 2014 Now available, Supportstore carries 20 different awareness items to help spread the word about skin cancer. The company is acutely aware of skin cancer issues as four of the six employees have themselves experienced various stages of skin cancer, including basal cell carcinoma, in citu melanoma, and earlier stage...

2014-05-30 08:25:19

Validation Data on More Than 300 Patients to be Released at the 2014 American Society of Oncology (ASCO) Annual Meeting REDWOOD CITY, Calif., May 30, 2014 /PRNewswire/ -- Guardant Health, a healthcare company focused on the development and commercialization of oncology diagnostic products, announced today that its premier product, Guardant360(TM) is now widely commercially available following recent successful introduction to early access partners....

2014-05-30 08:25:14

Retrospective Analysis Demonstrates Survival Benefits for Patients with Stable and Progressive Disease after HD IL-2 in the Modern Era Suggesting Appropriate Drug Sequencing May Improve Outcomes CHICAGO, May 30, 2014 /PRNewswire/ -- Prometheus Laboratories Inc. announced today that analysis of data from the PROCLAIM(SM) national patient registry retrospective cohort shows improved overall survival in metastatic RCC patients treated with high-dose Proleukin(®) (aldesleukin) in the...

2014-05-29 12:28:43

Backed by Science, the La Roche-Posay SOS--Save Our Skin Program and the WDS--Play Safe in The Sun Program are leading the charge to increase sun safe behavior for all ethnicities NEW YORK, May 29, 2014 /PRNewswire/ -- Skin cancer might not seem like a significant health threat for those with darker skin tones, but according to recent studies, it should be. One out of five Americans will get skin cancer(2), and although melanoma incidence is higher in Caucasians, the 5-year survival rates for...

2014-05-28 04:24:16

Canadians need to protect themselves more from dangerous ultraviolet rays TORONTO, May 28, 2014 /CNW/ - Melanoma skin cancer is one of the fastest rising of all cancers in Canada; Canadians need to do more to protect themselves from damaging ultraviolet (UV) radiation, according to a special report on skin cancer. Canadian Cancer Statistics 2014 was released today by the Canadian Cancer Society in partnership with the Public Health Agency of Canada and Statistics Canada. Skin...

2014-05-27 23:04:29

Dr. Peyman Ghasri now offers Mohs micrographic surgery to treat Squamous skin cancer, Basal Cell skin cancer, and Melanoma. Los Angeles, CA (PRWEB) May 27, 2014 Los Angeles skin cancer doctor, Dr. Peyman Ghasri, now offers Mohs micrographic surgery to treat skin cancer. More than two million Americans are diagnosed with skin cancer every year, and more skin cancers are diagnosed than breast cancers, lung cancers, colon cancers and prostate cancers combined. Mohs micrographic surgery is...

2014-05-27 08:29:27

Initial Responses Seen Before Patients Have Completed Treatments; BETHESDA, Md., May 27, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today provided a summary of initial data to date in its ongoing Phase I/II clinical trial of DCVax-Direct for all types of inoperable solid tumors. The Company reported that over 50% of the patients who have completed at least half of...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related